glucagon injection, solution
glucagon injection, solution is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Gvoke PFS 1 mg Pre-filled Syringe, Gvoke Kit, Gvoke HypoPen 0.5 mg Auto-Injector. Available dosage form: injection, solution.
Drug Details
- Generic Name
- glucagon injection, solution
- Brand Names
- Gvoke PFS 1 mg Pre-filled Syringe, Gvoke Kit, Gvoke HypoPen 0.5 mg Auto-Injector, Gvoke HypoPen 1 mg Auto-Injector
- Application Number
- NDA212097
- Sponsor
- Xeris Pharmaceuticals, Inc.
- NDC Codes
- 4
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GLUCAGON
Indications and Usage
1 INDICATIONS AND USAGE GVOKE is an antihypoglycemic agent indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged two years and older with diabetes ( 1.1 ) GVOKE VialDx is a gastrointestinal motility inhibitor indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients ( 1.2 ) 1.1 Severe Hypoglycemia in Adult and Pediatric Patients Aged 2 Years and Older with Diabetes GVOKE is indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged two and older with diabetes. 1.2 Diagnostic Aid in Adults GVOKE VialDx is indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.